BRAIN Biotech Future Growth
Future criteria checks 4/6
BRAIN Biotech is forecast to grow earnings and revenue by 70.9% and 11.9% per annum respectively while EPS is expected to grow by 69.5% per annum.
Key information
70.9%
Earnings growth rate
69.5%
EPS growth rate
Chemicals earnings growth | 16.5% |
Revenue growth rate | 11.9% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | n/a |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
9/30/2025 | 73 | 5 | N/A | 9 | 2 |
9/30/2024 | 68 | -1 | -2 | 1 | 4 |
9/30/2023 | 58 | -6 | -7 | -3 | 4 |
9/30/2022 | 50 | -9 | -12 | -4 | 4 |
6/30/2022 | 48 | -8 | -3 | -2 | N/A |
3/31/2022 | 44 | -8 | -4 | -1 | N/A |
12/31/2021 | 41 | -4 | -3 | -2 | N/A |
9/30/2021 | 39 | -5 | -5 | -4 | N/A |
6/30/2021 | 37 | -6 | -5 | -2 | N/A |
3/31/2021 | 37 | -6 | -6 | -5 | N/A |
12/31/2020 | 37 | -11 | -9 | -6 | N/A |
9/30/2020 | 39 | -10 | -8 | -5 | N/A |
6/30/2020 | 41 | -9 | -11 | -4 | N/A |
3/31/2020 | 41 | -12 | -11 | -5 | N/A |
12/31/2019 | 41 | -12 | -10 | -4 | N/A |
9/30/2019 | 40 | -11 | -10 | -3 | N/A |
6/30/2019 | 39 | -9 | -5 | -4 | N/A |
3/31/2019 | 37 | -7 | -9 | -5 | N/A |
12/31/2018 | 33 | -7 | -8 | -7 | N/A |
9/30/2018 | 29 | -8 | -7 | -5 | N/A |
6/30/2018 | 27 | -9 | -9 | -8 | N/A |
3/31/2018 | 25 | -8 | -7 | -6 | N/A |
12/31/2017 | 26 | -7 | -6 | -4 | N/A |
9/30/2017 | 26 | -10 | -7 | -6 | N/A |
6/30/2017 | 26 | -14 | -7 | -6 | N/A |
3/31/2017 | 26 | -14 | -8 | -6 | N/A |
12/31/2016 | 25 | -17 | -8 | -6 | N/A |
9/30/2016 | 25 | -15 | -10 | -9 | N/A |
6/30/2016 | 24 | -10 | -8 | -8 | N/A |
3/31/2016 | 24 | -9 | N/A | -6 | N/A |
12/31/2015 | 24 | -7 | N/A | -5 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BNND is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).
Earnings vs Market: BNND is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: BNND is expected to become profitable in the next 3 years.
Revenue vs Market: BNND's revenue (11.9% per year) is forecast to grow faster than the UK market (4% per year).
High Growth Revenue: BNND's revenue (11.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BNND's Return on Equity is forecast to be high in 3 years time